Skip to search formSkip to main contentSkip to account menu

PSA Velocity

Known as: Prostate Specific Antigen Velocity 
A measurement of how fast PSA levels in the blood increase over time. A high PSA velocity may be a sign of prostate cancer and may help find fast… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy
PurposeTo evaluate the accuracy of contrast-enhanced 18F-choline PET/CT in restaging patients with prostate cancer after radical… 
Highly Cited
2012
Highly Cited
2012
High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound‐guided template saturation biopsy
Study Type – Diagnostic (exploratory cohort) 
Highly Cited
2012
Highly Cited
2012
A comparative performance analysis of total prostate‐specific antigen, percentage free prostate‐specific antigen, prostate‐specific antigen velocity and urinary prostate cancer gene 3 in the first…
Study Type – Diagnosis (exploratory cohort) 
Highly Cited
2012
Highly Cited
2012
Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy.
Highly Cited
2010
Highly Cited
2010
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
PurposeThe aim of this study was to evaluate the potential usefulness of whole-body 11C-choline PET/CT in the re-staging of… 
Highly Cited
2009
Highly Cited
2009
Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy
The purpose of this study was to investigate the effect of total prostate-specific antigen (PSA) at the time of 11C-choline PET… 
Highly Cited
2007
Highly Cited
2007
Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study.
Highly Cited
2007
Highly Cited
2007
Clinical safety of a viral vector based prostate cancer vaccine strategy.
Review
2001
Review
2001
Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.
Review
1996
Review
1996
Pitfalls in interpreting prostate specific antigen velocity.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)